Back
Invesco FTSE RAFI Dev Mkts ex-US ETF Vs. Ultragenyx Pharmaceutical Industry Stock Comparison
Sell
40
PXF
Invesco FTSE RAFI Dev Mkts ex-US ETF
Last Price:
48.89
Seasonality Move:
0.55%
Sell
43
RARE
Ultragenyx Pharmaceutical
Last Price:
39.82
Seasonality Move:
-0.9%
Sell
40
Invesco FTSE RAFI Dev Mkts ex-US ETF (PXF)
is a Sell
Is Invesco FTSE RAFI Dev Mkts ex-US ETF a Buy, Sell or Hold?
- The current Invesco FTSE RAFI Dev Mkts ex-US ETF [PXF] share price is $48.80. The Score for PXF is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
- PXF is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
43
Ultragenyx Pharmaceutical (RARE)
is a Sell
Is Ultragenyx Pharmaceutical a Buy, Sell or Hold?
- The current Ultragenyx Pharmaceutical [RARE] share price is $39.39. The Score for RARE is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
- RARE is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
PXF Stock Price Chart
What is Invesco FTSE RAFI Dev Mkts ex-US ETF's stock price today?
-
The Invesco FTSE RAFI Dev Mkts ex-US ETF share price today is $48.80
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PXF is experiencing slight selling pressure.
RARE Stock Price Chart
What is Ultragenyx Pharmaceutical's stock price today?
-
The Ultragenyx Pharmaceutical share price today is $39.39
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RARE is experiencing selling pressure, which indicates risk of future bearish movement.
PXF Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.32 | Sell |
| Relative Strength Index (14 RSI): | 38.74 | Sell |
| Chaikin Money Flow: | -66870 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (49.31 - 50.87) | Sell |
| Bollinger Bands (100): | (47.73 - 50.25) | Sell |
RARE Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.74 | Sell |
| Relative Strength Index (14 RSI): | 45.16 | Sell |
| Chaikin Money Flow: | -377368 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (38.89 - 42.13) | Sell |
| Bollinger Bands (100): | (40.93 - 48.81) | Sell |
PXF Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 49.13 | Sell |
| 20-day SMA: | 49.92 | Sell |
| 50-day SMA: | 49.66 | Sell |
| 200-day SMA: | 46.94 | Buy |
| 8-day EMA: | 49.18 | Sell |
| 20-day EMA: | 49.64 | Sell |
| 50-day EMA: | 49.61 | Sell |
| 200-day EMA: | 47.62 | Buy |
RARE Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 40.13 | Sell |
| 20-day SMA: | 40.38 | Sell |
| 50-day SMA: | 41.72 | Sell |
| 200-day SMA: | 42.46 | Sell |
| 8-day EMA: | 39.68 | Sell |
| 20-day EMA: | 40.43 | Sell |
| 50-day EMA: | 41.92 | Sell |
| 200-day EMA: | 43.42 | Sell |
Invesco FTSE RAFI Dev Mkts ex-US ETF Earnings Growth & PXF Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Ultragenyx Pharmaceutical Earnings Growth & RARE Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.49 per share, an increase next quarter of $0.01 per share, an increase this year of $0.90 per share, and an increase next year of $1.07 per share.
Invesco FTSE RAFI Dev Mkts ex-US ETF Technical Analysis
| Jun 10 | Jun 11 | Jun 12 | Jun 13 | Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | ||||||||||
| 10 | 11 | 12 | 13 | 14 | 17 | 18 | 20 | 21 | 24 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Ultragenyx Pharmaceutical Technical Analysis
| Jun 10 | Jun 11 | Jun 12 | Jun 13 | Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | ||||||||||
| 10 | 11 | 12 | 13 | 14 | 17 | 18 | 20 | 21 | 24 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||